Personalized check and optimization of the patient's current medication plan according to the latest scientific achievements and pharmacogenetic profile:

Pharmacogenetic panel testing

Check and adjustment of medication for your conditions

Check of dose with adjustment for your kidney and liver function

Identification of drug interactions for patients taking multiple drugs

Optimal control of cardiovascular risk factors

Blood pressure control with optional remote real time monitoring using the latest convenience technology

Lowering of high cholesterol with latest convenience and safe drugs

Prevention and evaluation of adverse drug reactions

Evaluation and optimization of dietary supplements

Adjunct Professor of Epidemiology at Boston University 2005-2021 (USA)

Research Fellow with Boston Collaborative Drug Surveillance Program (BCDSP), USA (2004-2006)

St. Mary's Hospital Medical School at Imperial College London

Consulting senior physician at Hirslanden Hospital Zurich

Medical studies at Albert-Ludwigs University Freiburg (GER) and St. Mary’s Hospital at Imperial College London (UK)

Adjunct Professor of Clinical Pharmacology and Toxicology at University of Zurich

Lecturer of Pharmacoepidemiology at ETH Zurich

Author of more than 60 international leading research publications in the fields of clinical pharmacology, pharmacoepidemiology, drug safety, hepatotoxicity, gastroenterology, nephrology, cardiology and pharmacogenetics

State-of-the-art pharmacotherapy, prevention of drug interactions and adverse drug reactions

Pharmacological prevention and treatment of cardiovascular and cerebrovascular diseases (including myocardial infarction and stroke)

Toxic liver disease

Autosomal dominant polycystic kidney disease (ADPKD): Latest treatment options for delay of disease progression (in collaboration with nephrologist)

Irritable bowel syndrome: consultation on personalized diet, dietary supplements and medication

Pharmacogenetics: genetic testing with personalized adjustment of medication based on your individual pharmacogenetic profile